- Home
- EVO vs NN Comparison
EVO vs NN Comparison
Compare EVO & NN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVO
- NN
- Stock Information
- Founded
- EVO 1993
- NN 2007
- Country
- EVO Germany
- NN United States
- Employees
- EVO N/A
- NN N/A
- Industry
- EVO Biotechnology: Pharmaceutical Preparations
- NN Industrial Machinery/Components
- Sector
- EVO Health Care
- NN Industrials
- Exchange
- EVO Nasdaq
- NN Nasdaq
- Market Cap
- EVO 1.6B
- NN 1.4B
- IPO Year
- EVO 2021
- NN N/A
- Fundamental
- Price
- EVO $3.36
- NN $12.17
- Analyst Decision
- EVO Buy
- NN
- Analyst Count
- EVO 2
- NN 0
- Target Price
- EVO $5.90
- NN N/A
- AVG Volume (30 Days)
- EVO 114.9K
- NN 1.7M
- Earning Date
- EVO 05-21-2025
- NN 03-12-2025
- Dividend Yield
- EVO N/A
- NN N/A
- EPS Growth
- EVO N/A
- NN N/A
- EPS
- EVO N/A
- NN N/A
- Revenue
- EVO $866,665,179.00
- NN $5,669,000.00
- Revenue This Year
- EVO $3.70
- NN $43.04
- Revenue Next Year
- EVO $10.32
- NN $123.84
- P/E Ratio
- EVO N/A
- NN N/A
- Revenue Growth
- EVO N/A
- NN 46.79
- 52 Week Low
- EVO $2.85
- NN $6.47
- 52 Week High
- EVO $7.98
- NN $18.54
- Technical
- Relative Strength Index (RSI)
- EVO 33.58
- NN 52.20
- Support Level
- EVO $3.25
- NN $12.37
- Resistance Level
- EVO $3.63
- NN $13.53
- Average True Range (ATR)
- EVO 0.09
- NN 0.99
- MACD
- EVO 0.00
- NN 0.19
- Stochastic Oscillator
- EVO 25.58
- NN 63.21
Stock Price Comparison Chart: EVO vs NN
About EVO Evotec SE
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
About NN NextNav Inc.
NextNav Inc provides GPS service. The company NextNav TerraPoiNT system keeps critical infrastructure resilient with reliable Position, Navigation and Timing services in the absence of GPS.